• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能化磷脂纳米粒子表面对补体的可变抗体依赖性激活。

Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.

机构信息

Divisions of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

J Biol Chem. 2011 Jan 7;286(1):123-30. doi: 10.1074/jbc.M110.180760. Epub 2010 Nov 3.

DOI:10.1074/jbc.M110.180760
PMID:21047788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3012966/
Abstract

A wide variety of nanomaterials are currently being developed for use in the detection and treatment of human diseases. However, there is no systematic way to measure and predict the action of such materials in biological contexts. Lipid-encapsulated nanoparticles (NPs) are a class of nanomaterials that includes the liposomes, the most widely used and clinically proven type of NPs. Liposomes can, however, activate the complement system, an important branch of innate immunity, resulting in undesirable consequences. Here, we describe the complement response to lipid-encapsulated NPs that are functionalized on the surface with various lipid-anchored gadolinium chelates. We developed a quantitative approach to examine the interaction of NPs with the complement system using in vitro assays and correlating these results with those obtained in an in vivo mouse model. Our results indicate that surface functionalization of NPs with certain chemical structures elicits swift complement activation that is initiated by a natural IgM antibody and propagated via the classical pathway. The intensity of the response is dependent on the chemical structures of the lipid-anchored chelates and not zeta potential effects alone. Moreover, the extent of complement activation may be tempered by complement inhibiting regulatory proteins that bind to the surface of NPs. These findings represent a step forward in the understanding of the interactions between nanomaterials and the host innate immune response and provide the basis for a systematic structure-activity relationship study to establish guidelines that are critical to the future development of biocompatible nanotherapeutics.

摘要

目前正在开发各种纳米材料用于人类疾病的检测和治疗。然而,目前还没有系统的方法来测量和预测这些材料在生物环境中的作用。脂质体包被的纳米颗粒(NPs)是一类纳米材料,包括脂质体,这是最广泛使用和临床验证的 NPs 类型。然而,脂质体可以激活补体系统,这是先天免疫的一个重要分支,从而导致不良后果。在这里,我们描述了脂质体包被的 NPs 与补体系统的相互作用,这些 NPs 的表面用各种脂质锚定的钆螯合物进行了功能化。我们开发了一种定量方法来使用体外测定来检查 NPs 与补体系统的相互作用,并将这些结果与在体内小鼠模型中获得的结果相关联。我们的结果表明,NPs 表面的某些化学结构的功能化会引发迅速的补体激活,这种激活是由天然 IgM 抗体引发的,并通过经典途径传播。反应的强度取决于脂质锚定螯合物的化学结构,而不仅仅是 zeta 电位效应。此外,补体激活的程度可能会受到与 NPs 表面结合的补体抑制调节蛋白的调节。这些发现代表了在理解纳米材料与宿主先天免疫反应之间相互作用方面的一个进步,并为建立对未来生物相容性纳米治疗学的发展至关重要的系统结构-活性关系研究提供了基础。

相似文献

1
Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.功能化磷脂纳米粒子表面对补体的可变抗体依赖性激活。
J Biol Chem. 2011 Jan 7;286(1):123-30. doi: 10.1074/jbc.M110.180760. Epub 2010 Nov 3.
2
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.具有异质表面官能团的脂质-聚合物杂化纳米颗粒的免疫相容性特性
Biomaterials. 2009 Apr;30(12):2231-40. doi: 10.1016/j.biomaterials.2009.01.005. Epub 2009 Jan 23.
3
Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.纳米颗粒表面蛋白冠的形成会影响 C1q 介导的不同补体激活途径。
Pharm Res. 2019 Dec 23;37(1):10. doi: 10.1007/s11095-019-2747-8.
4
How antibodies use complement to regulate antibody responses.抗体如何利用补体来调节抗体应答。
Mol Immunol. 2014 Oct;61(2):79-88. doi: 10.1016/j.molimm.2014.06.010. Epub 2014 Jul 4.
5
Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies.脂质体包裹血红蛋白对人血清补体的激活作用:天然抗磷脂抗体的作用
Biochim Biophys Acta. 1996 Dec 4;1285(2):127-30. doi: 10.1016/s0005-2736(96)00201-5.
6
Antibody dependent, complement mediated liver uptake of liposomes containing GM1.抗体依赖的、补体介导的含GM1脂质体的肝脏摄取。
Pharm Res. 1995 Nov;12(11):1775-80. doi: 10.1023/a:1016286310475.
7
Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.副流感病毒中和过程中一种非中和性IgM抗体与补体的相互作用。
Virology. 1988 Dec;167(2):433-41.
8
A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.实验性肺炎球菌菌血症中抗肺炎球菌抗体与补体相互作用的定量分析
J Clin Invest. 1982 Jan;69(1):85-98. doi: 10.1172/jci110444.
9
Antibody and complement-binding activity of viable and nonviable human spermatozoa.活的和死的人类精子的抗体及补体结合活性
Arch Androl. 1987;18(3):189-97. doi: 10.3109/01485018708988482.
10
Human Secretory IgM Antibodies Activate Human Complement and Offer Protection at Mucosal Surface.人分泌型 IgM 抗体激活人补体并在黏膜表面提供保护。
Scand J Immunol. 2017 Jan;85(1):43-50. doi: 10.1111/sji.12508.

引用本文的文献

1
Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases.在针对传染病和非传染病的预防性和治疗性疫苗策略中使用补体成分的优势。
J R Soc Interface. 2025 Jul;22(228):20250138. doi: 10.1098/rsif.2025.0138. Epub 2025 Jul 2.
2
Ionizable lipid nanoparticles of mRNA vaccines elicit NF-κB and IRF responses through toll-like receptor 4.信使核糖核酸疫苗的可电离脂质纳米颗粒通过Toll样受体4引发核因子κB和干扰素调节因子反应。
NPJ Vaccines. 2025 Apr 17;10(1):73. doi: 10.1038/s41541-025-01124-x.
3
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.针对 RNA 治疗药物靶向递送而设计的脂质纳米粒的体内复杂旅程的探索:一种基于质量设计的方法。
J Nanobiotechnology. 2024 Nov 14;22(1):710. doi: 10.1186/s12951-024-02972-w.
4
Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines.刀刃上的平衡:mRNA 疫苗的免疫原性和反应原性。
Exp Mol Med. 2023 Jul;55(7):1305-1313. doi: 10.1038/s12276-023-00999-x. Epub 2023 Jul 10.
5
Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics.嗜碱性细胞系KU812暴露于脂质体显示出与潜在过敏反应相关的激活谱,这些反应与物理化学特性有关。
Pharmaceutics. 2022 Nov 15;14(11):2470. doi: 10.3390/pharmaceutics14112470.
6
Revisiting the outstanding questions in cancer nanomedicine with a future outlook.展望未来,重新审视癌症纳米医学中的突出问题。
Nanoscale Adv. 2021 Dec 22;4(3):634-653. doi: 10.1039/d1na00810b. eCollection 2022 Feb 1.
7
Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects.mRNA-LNP 治疗学的最新进展:免疫学和药理学方面。
J Nanobiotechnology. 2022 Jun 14;20(1):276. doi: 10.1186/s12951-022-01478-7.
8
Cationic Nanomaterials for Autoimmune Diseases Therapy.用于自身免疫性疾病治疗的阳离子纳米材料
Front Pharmacol. 2022 Jan 21;12:762362. doi: 10.3389/fphar.2021.762362. eCollection 2021.
9
Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety.LNP-mRNA的非免疫治疗应用:最大化疗效与安全性
Biomedicines. 2021 May 10;9(5):530. doi: 10.3390/biomedicines9050530.
10
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.纳米颗粒诱导的补体激活:对癌症纳米医学的启示。
Front Immunol. 2021 Jan 8;11:603039. doi: 10.3389/fimmu.2020.603039. eCollection 2020.

本文引用的文献

1
Complement: a key system for immune surveillance and homeostasis.补体:免疫监视和稳态的关键系统。
Nat Immunol. 2010 Sep;11(9):785-97. doi: 10.1038/ni.1923. Epub 2010 Aug 19.
2
Strategies in the design of nanoparticles for therapeutic applications.用于治疗应用的纳米粒子设计策略。
Nat Rev Drug Discov. 2010 Aug;9(8):615-27. doi: 10.1038/nrd2591. Epub 2010 Jul 9.
3
Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?治疗医学中的细胞和生物材料能否免受固有免疫识别?
Trends Immunol. 2010 Jan;31(1):32-8. doi: 10.1016/j.it.2009.09.005.
4
The role of the anaphylatoxins in health and disease.过敏毒素在健康与疾病中的作用。
Mol Immunol. 2009 Sep;46(14):2753-66. doi: 10.1016/j.molimm.2009.04.027. Epub 2009 May 28.
5
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.整合素靶向烟曲霉素纳米颗粒与阿托伐他汀在动脉粥样硬化中的抗血管生成协同作用
JACC Cardiovasc Imaging. 2008 Sep;1(5):624-34. doi: 10.1016/j.jcmg.2008.06.003.
6
Immunological properties of engineered nanomaterials.工程纳米材料的免疫特性
Nat Nanotechnol. 2007 Aug;2(8):469-78. doi: 10.1038/nnano.2007.223. Epub 2007 Jul 29.
7
Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.微小剂量的α(nu)β3靶向烟曲霉素纳米颗粒可抑制兔VX-2肿瘤血管生成和生长。
FASEB J. 2008 Aug;22(8):2758-67. doi: 10.1096/fj.07-103929. Epub 2008 Mar 24.
8
Complement evasion by human pathogens.人类病原体的补体逃避
Nat Rev Microbiol. 2008 Feb;6(2):132-42. doi: 10.1038/nrmicro1824.
9
Nanotoxicity: the growing need for in vivo study.纳米毒性:体内研究的迫切需求。
Curr Opin Biotechnol. 2007 Dec;18(6):565-71. doi: 10.1016/j.copbio.2007.11.008. Epub 2007 Dec 21.
10
Complement driven by conformational changes.由构象变化驱动的补体。
Nat Rev Immunol. 2008 Jan;8(1):48-58. doi: 10.1038/nri2231.